[HLBANK] YoY Annualized Quarter Result on 30-Jun-2015 [#4]

Announcement Date
26-Aug-2015
Admission Sponsor
-
Sponsor
-
Financial Year
30-Jun-2015
Quarter
30-Jun-2015 [#4]
Profit Trend
QoQ- 3.49%
YoY- 6.23%
View:
Show?
Annualized Quarter Result
30/06/18 30/06/17 30/06/16 30/06/15 30/06/14 30/06/13 30/06/12 CAGR
Revenue 4,839,565 4,550,649 4,177,862 4,066,948 4,039,059 4,006,795 3,877,605 3.76%
PBT 3,246,255 2,748,252 2,381,699 2,746,158 2,613,221 2,392,947 2,236,157 6.40%
Tax -608,177 -603,236 -478,282 -512,971 -510,951 -536,675 -492,562 3.57%
NP 2,638,078 2,145,016 1,903,417 2,233,187 2,102,270 1,856,272 1,743,595 7.14%
-
NP to SH 2,638,078 2,145,016 1,903,417 2,233,187 2,102,270 1,856,272 1,743,595 7.14%
-
Tax Rate 18.73% 21.95% 20.08% 18.68% 19.55% 22.43% 22.03% -
Total Cost 2,201,487 2,405,633 2,274,445 1,833,761 1,936,789 2,150,523 2,134,010 0.51%
-
Net Worth 23,893,507 22,684,628 19,683,995 16,801,905 14,511,773 12,999,693 11,095,113 13.63%
Dividend
30/06/18 30/06/17 30/06/16 30/06/15 30/06/14 30/06/13 30/06/12 CAGR
Div 981,924 920,476 782,019 724,372 722,066 789,455 631,159 7.64%
Div Payout % 37.22% 42.91% 41.09% 32.44% 34.35% 42.53% 36.20% -
Equity
30/06/18 30/06/17 30/06/16 30/06/15 30/06/14 30/06/13 30/06/12 CAGR
Net Worth 23,893,507 22,684,628 19,683,995 16,801,905 14,511,773 12,999,693 11,095,113 13.63%
NOSH 2,167,718 2,167,718 2,167,718 1,766,761 1,761,137 1,754,344 1,660,945 4.53%
Ratio Analysis
30/06/18 30/06/17 30/06/16 30/06/15 30/06/14 30/06/13 30/06/12 CAGR
NP Margin 54.51% 47.14% 45.56% 54.91% 52.05% 46.33% 44.97% -
ROE 11.04% 9.46% 9.67% 13.29% 14.49% 14.28% 15.71% -
Per Share
30/06/18 30/06/17 30/06/16 30/06/15 30/06/14 30/06/13 30/06/12 CAGR
RPS 236.58 222.47 219.04 230.19 229.34 228.39 233.46 0.22%
EPS 128.96 104.86 99.79 126.40 119.37 105.81 104.97 3.48%
DPS 48.00 45.00 41.00 41.00 41.00 45.00 38.00 3.96%
NAPS 11.68 11.09 10.32 9.51 8.24 7.41 6.68 9.75%
Adjusted Per Share Value based on latest NOSH - 1,766,813
30/06/18 30/06/17 30/06/16 30/06/15 30/06/14 30/06/13 30/06/12 CAGR
RPS 223.26 209.93 192.73 187.61 186.33 184.84 178.88 3.76%
EPS 121.70 98.95 87.81 103.02 96.98 85.63 80.43 7.14%
DPS 45.30 42.46 36.08 33.42 33.31 36.42 29.12 7.63%
NAPS 11.0224 10.4647 9.0805 7.751 6.6945 5.9969 5.1183 13.63%
Price Multiplier on Financial Quarter End Date
30/06/18 30/06/17 30/06/16 30/06/15 30/06/14 30/06/13 30/06/12 CAGR
Date 29/06/18 30/06/17 30/06/16 30/06/15 30/06/14 28/06/13 29/06/12 -
Price 18.20 15.66 13.18 13.40 13.80 13.90 12.44 -
P/RPS 7.69 7.04 6.02 5.82 6.02 6.09 5.33 6.29%
P/EPS 14.11 14.93 13.21 10.60 11.56 13.14 11.85 2.95%
EY 7.09 6.70 7.57 9.43 8.65 7.61 8.44 -2.86%
DY 2.64 2.87 3.11 3.06 2.97 3.24 3.05 -2.37%
P/NAPS 1.56 1.41 1.28 1.41 1.67 1.88 1.86 -2.88%
Price Multiplier on Announcement Date
30/06/18 30/06/17 30/06/16 30/06/15 30/06/14 30/06/13 30/06/12 CAGR
Date 28/08/18 24/08/17 29/08/16 26/08/15 26/08/14 29/08/13 28/08/12 -
Price 20.00 15.50 13.12 12.92 14.00 13.70 13.50 -
P/RPS 8.45 6.97 5.99 5.61 6.10 6.00 5.78 6.53%
P/EPS 15.51 14.78 13.15 10.22 11.73 12.95 12.86 3.17%
EY 6.45 6.77 7.61 9.78 8.53 7.72 7.78 -3.07%
DY 2.40 2.90 3.13 3.17 2.93 3.28 2.81 -2.59%
P/NAPS 1.71 1.40 1.27 1.36 1.70 1.85 2.02 -2.73%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ & YoY figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments

Post a Comment